Alexandra Klikoff, MD
Obstetrics/Gynecology · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 1 carrier
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Klikoff’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence G83647 · Current
Licensed to practise in California · since 1997 · expires 2027-03-31 · University of California, Davis School of Medicine. Board flags: Public Reprimand.
Public record actions
| 2021-01-14 | Board disciplineDiscipline | Public reprimand. · 8002015016546 |
Medicaid work
$740 in 2024
Medicaid paid $740 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $740 |
| 2024 | 12 | 1 | 12 | $740 |
Drugs they prescribed that Part D paid
$19,959
Pharmacies billed $19,959 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 161) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
140 generic and 21 brand-name prescriptions · $19,959 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 48 | $1,754 | $37 |
| Yuvafem | 13 | $1,268 | $98 |
| Progesterone | 15 | $881 | $59 |
| Fluconazole | 12 | $75 | $6 |
Year by year
| 2024 | 161 | 63 | 0% (0) | 13% | $19,959 |
| 2023 | 133 | 60 | 0% (0) | 16% | $16,301 |
| 2022 | 108 | 52 | 0% (0) | 12% | $10,097 |
| 2021 | 106 | 50 | 0% (0) | 14% | $11,510 |
| 2020 | 114 | 51 | 0% (0) | 18% | $13,103 |
| 2019 | 82 | 43 | 0% (0) | 21% | $7,582 |
| 2018 | 60 | 29 | 0% (0) | 23% | $5,721 |
| 2017 | 126 | 35 | None | 33% | $8,662 |
| 2016 | 360 | 53 | None | 31% | $21,182 |
| 2015 | 333 | 54 | None | 33% | $21,785 |
| 2014 | 215 | 46 | None | 41% | $17,469 |
| 2013 | 136 | 27 | None | 57% | $8,969 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Estradiol | 50 | $2,006 | $40 |
| Acyclovir | 11 | $141 | $13 |
2022: 1 drug
| Estradiol | 35 | $1,232 | $35 |
2021: 1 drug
| Estradiol | 49 | $1,757 | $36 |
2020: 1 drug
| Estradiol | 54 | $3,028 | $56 |
2019: 1 drug
| Estradiol | 30 | $932 | $31 |
2018: 2 drugs
| Estrace | 14 | $1,526 | $109 |
| Estradiol | 15 | $382 | $25 |
2017: 2 drugs
| Estradiol | 46 | $2,767 | $60 |
| Trazodone | 12 | $28 | $2 |
2016: 11 drugs
| Estradiol | 87 | $4,787 | $55 |
| Estrace | 11 | $2,886 | $262 |
| Premarin | 12 | $2,856 | $238 |
| Progesterone | 28 | $1,448 | $52 |
| Norethindrone Acetate | 14 | $921 | $66 |
| Oxybutynin Chloride Er | 12 | $439 | $37 |
| Valacyclovir | 11 | $292 | $27 |
| Cyclafem | 12 | $222 | $19 |
| Medroxyprogesterone Acetate | 19 | $178 | $9 |
| Trazodone | 34 | $129 | $4 |
| Paroxetine | 15 | $123 | $8 |
2015: 9 drugs
| Estradiol | 70 | $4,069 | $58 |
| Premarin | 13 | $3,557 | $274 |
| Progesterone | 25 | $1,863 | $75 |
| Combipatch | 13 | $1,626 | $125 |
| Levothyroxine | 20 | $469 | $23 |
| Cyclafem | 13 | $232 | $18 |
| Medroxyprogesterone Acetate | 25 | $187 | $7 |
| Trazodone | 31 | $148 | $5 |
| Escitalopram | 11 | $72 | $7 |
2014: 7 drugs
| Vivelle-Dot | 36 | $4,204 | $117 |
| Premarin | 14 | $3,015 | $215 |
| Progesterone | 13 | $1,122 | $86 |
| Estradiol | 24 | $1,117 | $47 |
| Levothyroxine | 11 | $240 | $22 |
| Medroxyprogesterone Acetate | 17 | $130 | $8 |
| Trazodone | 19 | $125 | $7 |
2013: 4 drugs
| Vivelle-Dot | 20 | $2,026 | $101 |
| Estradiol | 26 | $1,562 | $60 |
| Progesterone | 17 | $1,109 | $65 |
| Levothyroxine | 13 | $119 | $9 |
Money from drug and device companies
$47 in 2025
| 2025 | 1 | 1 | None | $47 |
| 2024 | 1 | 1 | None | $54 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Jetstream Sc | $47 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-06-10 | Jetstream Sc | $47 |
See earlier years (2024)
2024: $54
| Boston Scientific | None | $54 | 1 payment
|
Professional record
- NPI
- 1538237755
- Licence
- CA G83647California G83647: Current · expires 2027-03-31
- Trained
- University of California, Davis School of Medicine, 1993
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 3275 Aptos Rancho Rd, Suite E, Aptos, CA, 95003
- NPI first listed
- 2006-12-04
- NPI last updated
- 2022-01-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.